ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,438.65
-0.08%
Dow Jones
39,869.38
-0.10%
Gold vs US Dollar
2,377.99
-0.01%
Brent Oil
83.215
0.01%
Bitcoin
65,398.31
0.24%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV
  6. Neovasc Inc. (NVC)

  7. Neovasc Inc. (NVC) News

Neovasc Inc. (NVC)

Neovasc Inc.
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:NVC
DateTimeSourceHeadlineSymbolCompany
20/06/201412:00PR Newswire (Canada)Neovasc Inc. Announces Receipt of Final Approval to Graduate to the TSXTSXV:NVCNeovasc Inc.
19/06/201412:00PR Newswire (Canada)Neovasc Inc. reports results of Annual General Meeting of ShareholdersTSXV:NVCNeovasc Inc.
12/06/201419:18PR Newswire (Canada)Neovasc earns a spot in 2014 PROFIT 500 ListTSXV:NVCNeovasc Inc.
06/06/201421:15PR Newswire (Canada)Neovasc Inc. provides initial comments on lawsuitTSXV:NVCNeovasc Inc.
22/05/201412:00PR Newswire (Canada)Neovasc Inc. reports financial results for first quarter 2014TSXV:NVCNeovasc Inc.
21/05/201415:45PR Newswire (Canada)Positive First-In-Human Experience With Neovasc's Tiara™ Transcatheter Mitral Valve Presented at EuroPCR 2014TSXV:NVCNeovasc Inc.
16/05/201412:00PR Newswire (Canada)Neovasc Inc. to begin trading on the NASDAQ Capital MarketTSXV:NVCNeovasc Inc.
13/05/201412:00PR Newswire (Canada)Neovasc Inc. Announces Upcoming Presentations at EuroPCR 2014TSXV:NVCNeovasc Inc.
08/05/201412:00PR Newswire (Canada)Neovasc Hires Industry Veteran Vicki Bebeau as Vice President, Clinical AffairsTSXV:NVCNeovasc Inc.
17/04/201423:17PR Newswire (Canada)Neovasc announces filing of shelf prospectus and application to list on NASDAQTSXV:NVCNeovasc Inc.
17/04/201412:00PR Newswire (Canada)Neovasc Inc. Reports Financial Results For 2013TSXV:NVCNeovasc Inc.
31/03/201412:00PR Newswire (Canada)COSIRA Study Data Presented at ACC.14 Confirms the Neovasc Reducer(TM) Improves Functional Capabilities in Refractory Angina ...TSXV:NVCNeovasc Inc.
26/03/201413:24Marketwired CanadaNeovasc Inc. Closes C$25 Million Bought Deal Equity FinancingTSXV:NVCNeovasc Inc.
17/03/201411:00PR Newswire (Canada)Neovasc Reducer™ for Refractory Angina Featured in Live Case Session at 10th Annual Congress of Update in Cardiology and Ca...TSXV:NVCNeovasc Inc.
04/03/201412:00PR Newswire (Canada)Neovasc Inc. Provides Update on Tiara™ Transcatheter Mitral Valve and Reducer™ ProgramsTSXV:NVCNeovasc Inc.
03/03/201420:42Marketwired CanadaNeovasc Announces C$25,152,000 Bought Deal Equity FinancingTSXV:NVCNeovasc Inc.
03/02/201412:15PR Newswire (Canada)Neovasc Inc. Announces Successful First Human Implant of Tiara™ Transcatheter Mitral ValveTSXV:NVCNeovasc Inc.
20/11/201312:28PR Newswire (Canada)Neovasc Inc. Reports Financial Results for Third Quarter of 2013TSXV:NVCNeovasc Inc.
13/11/201312:28PR Newswire (Canada)Neovasc receives first US patent for its novel Tiara(TM) transcatheter mitral valve replacement technologyTSXV:NVCNeovasc Inc.
06/11/201312:28PR Newswire (Canada)Neovasc Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients wit...TSXV:NVCNeovasc Inc.
29/10/201311:28PR Newswire (Canada)Neovasc Inc. Announces Publication of Positive Tiara™ Preclinical Data in the Journal JACC: Cardiovascular InterventionsTSXV:NVCNeovasc Inc.
24/10/201312:28PR Newswire (Canada)Neovasc Inc. announces upcoming presentations at TCT 2013 scientific symposiumTSXV:NVCNeovasc Inc.
15/08/201312:28PR Newswire (Canada)Neovasc Inc. reports financial results for second quarter of 2013TSXV:NVCNeovasc Inc.
28/05/201312:30PR Newswire (Canada)Neovasc Inc. Reports Financial Results for First Quarter of 2013TSXV:NVCNeovasc Inc.
23/05/201312:30PR Newswire (Canada)Positive Animal Data Presented at EuroPCR Sets Stage for Advancing Neovasc's Tiara(TM) Transcatheter Mitral Valve into Human ...TSXV:NVCNeovasc Inc.
21/05/201312:30PR Newswire (Canada)Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer™ Improves Cardiovascular Parameters in Refractory Angi...TSXV:NVCNeovasc Inc.
13/05/201312:25PR Newswire (Canada)Neovasc Inc. Completes Enrollment in COSIRA Trial Assessing Efficacy of Reducer™ Product for Treatment of Refractory AnginaTSXV:NVCNeovasc Inc.
29/04/201312:25PR Newswire (Canada)Neovasc Inc. reports financial results for 2012 year-endTSXV:NVCNeovasc Inc.
25/04/201312:30PR Newswire (Canada)Neovasc Inc. reports exercise of 1.8 million warrants for net proceeds of $2.3 millionTSXV:NVCNeovasc Inc.
28/02/201312:30PR Newswire (Canada)Neovasc's COSIRA clinical trial protocol selected for publication in peer-reviewed journalTSXV:NVCNeovasc Inc.
 Showing the most relevant articles for your search:TSXV:NVC

Your Recent History

LSE
BEEP
BLACKROCK EMERGING
LSE
UBM
UBM
COIN
MLNUSD
Enzyme Finance
LSE
SWL
Swallowfield
LSE
EXC
LSE
GOG
Go-ahead
LSE
RGD
Real Good Food
LSE
JMO
JP Morgan Fleming Overseas It
NASDAQ
BPOP
Popular
NASDAQ
DMED
LSE
DCTA
Directa Plus
LSE
COS
Collagen Solutions
COIN
ORDIEUR
Ordinals
LSE
MANA
LSE
NTA
Northacre
LSE
PCGB
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved